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PREFACE 
Over twenty years ago an IgG Fc-binding glycoprotein 
(gE) was identified in HSVl. Since then homologs of the 
gE gene have been identified in several other a-herpesvi-
ruses. The purpose of this study was to search for a 
homolog of the HSVl gE in SA8, a simian a-herpesvirus, 
and to determine its relationship to the HSVl gE gene. 
I would like to express my deepest appreciation and 
esteem to my major advisor, Dr. R. Eberle, for his toler-
ated guidence, financial support, great help in this 
study, and excellent editorial guidence in this paper. I 
would also like to express my thanks to Mrs. D. Black for 
her excellent technical assistance and sincere coopera-
tion. 
I would like to express my gratitude to my committee 
members, Dr. R.W. Fulton, Dr. J. d'Offay, and Dr. E. Short 
for their guidence and help. 
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Herpesviruses have been isolated from humans and 
numerous other animal species (1,2,3,4,5,6,12,13,14). The 
herpesvirus family is divided into three subfamilies, the 
a-, B-, and Y-herpesviruses, based on their biological and 
pathogenic properties (7) (Table 1). Some a-herpesviruses 
are human herpes simplex virus types 1 and 2 (HSV1, 
HSV2), varicella-zoster virus (VZV), simian agent 8 (SA8), 
Herpesvirus simiae (B virus), pseudorabies virus (PRV), 
bovine herpesviruses 1 and 2 (BHV1, BHV2), equine her-
pesviruses 1 and 4 (EHV1, EHV4), and channel catfish 
herpesvirus (CCV) (1,2,4,5,7,8,10). The a-herpesviruses 
are characterized by a rapid replication cycle which 
usually results in lysis of the infected cell and estab-
lishment of latent infections in sensory ganglionic neu-
rons (7,9). The B-herpesviruses are the cytomegaloviruses 
(CMV) which include human CMV, H. aotus 1 and 3, EHV2, and 
BHV4 (11,12,13,14). The B-herpesviruses are characterized 
by their relatively long replication cycle and establish-
ment of latent infections in salivary glands, kidneys, 
lymphoreticular tissue, and other tissues (11,15). The 
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GENERAL PROPERTIES OF MEMBERS OF THE HERPESVIRUS FAMILY 
AFFECTING HUMANS 








oro-facial, genital lesions, ocular infections, 
encephalitis 
Chickenpox in children (acute infection), shingles 
(zoster, recurrent infection) 
Hepatitis, lymphocytosis, respiratory infections, 
interstitial pneumonia in organ transplant 
patients, mental retardation and birth defects 
in infants 
Infectious mononucleosis, nasopharyngeal carcinoma, 
Burkett's lymphoma 
Y-herpesviruses include Epstein-Barr virus, H. saimiri 2, 
H. ateles 2, H. aotus 2, and gallid herpesvirus 2, 
(3,6,16,17). The Y-herpesviruses commonly cause oncogenic 
transformation of T or B lymphocytes and establish latent 
infections in lymphoid tissue (3,17). 
HSV1 and HSV2 belong to the a-herpesvirus group 
(1,7). Both HSV1 and HSV2 are common infectious agents in 
human beings and usually cause asymptomatic infection or 
clinical oro-facial lesions (18). HSV1 is usually ac-
quired from family members during childhood by close 
personal contact (1,18). HSV2 causes primarily genital 
infections in individuals and is acquired by venereal 
contact (1,19). HSV2 can also cause severe generalized 
disease in newborns when acquired at the time of birth by 
contact with the mother's infected birth canal (18). 
As is typical of herpesvirus infections, HSV infec-
tion can be divided into three types: acute, latent and 
recurrent (18,20,21). Although many primary (acute) 
infections are asymptomatic, local lesions are also common 
(18). After primary infection, HSV can remain latent in a 
noninfectious state in the body for the life of its host 
(18,21). Since the latent infection is commonly in senso-
ry nerve ganglia, recurrences are often caused by the 
reactivation of the virus due to stress, trauma or immuno-
suppression (20). Although HSV infections are usually 
asymptomatic or are clinically manifested as vesicles or 
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blisters on the face or other mucosal membrane of body, 
severe infections may also occur (18). These include 
ocular infections, encephalitis, and disseminated disease 
in newborns (18). In addition, HSV2 infection has been 
associated with cervical carcinoma (22). 
Herpesvirus virions consist of a core structure, an 
icosahedral capsid, a pleomorphic tegument, and an en-
velope (Figure 1). The core of the virion is composed of 
the viral DNA and basic andfor phosphoproteins (23). The 
structure of the core has been suggested to be of toroidal 
form, but this has not been confirmed so far (57). The 
herpesvirus icosahedral capsid is characteristically 
composed of 162 capsomeres which enclose the core struc-
ture (24). The tegument is located between the envelope 
and nucleocapsid and appears in the electron microscopy as 
an amorphous structure (25). The tegument is probably in-
volved in maintaining the shape or structure of the virion 
(25). Recent studies suggest that the tegument also 
includes some important proteins that regulate the tran-
scription of viral DNA (28). The envelope of herpesvi-
ruses consists of a lipid bilayer derived from the host 
cell in which are anchored viral glycoproteins (27). The 
surface glycoproteins appear as spikes when virions are 
examined by electron microscopy (26). The number and 
quantity of glycoproteins vary among different herpesvi-



































designated gB, gC, gD, gE, gG, gH and gi (15,26,58,60). 
The HSV genome is a linear double-stranded DNA mole-
cule (1). The genome is about 155x106 base pairs with a 
67% G+C composition (37). The genome is composed of two 
covalently linked parts, the large (L) region and the 
short (S) region (about 82% and 18% of the viral genome, 
respectively) (1,15,37). Both Lands consist largely of 
unique sequences enclosed by a pair of short inverted 
repeat sequences at either end (37) . These repeat se-
quences allow the L and s regions to invert their orienta-
tions during viral DNA replication (1,15,37). Consequent-
ly, four isomers of the HSV genome are found in infected 
cells which differ in the orientation of unique (non-
repeat) sequences within the L andfor s regions 
(1,12,15,37). 
The earliest stages of the herpesvirus infectious 
cycle, attachment and penetration, are mediated by the 
viral glycoproteins (43,44,45,59). Attachment to the host 
cell occurs by the formation of complexes between viral 
glycoproteins and appropriate receptors on the host cell 
membrane (59). Penetration then occurs by fusion of the 
viral envelope with the host cell plasma membrane (59). 
In HSV1, mutation of either the gB or gD glycoproteins 
causes the virus to lose the ability to penetrate cells 
(43,44). The gB and gD glycoproteins therefore appear to 
be somehow involved in viral penetration into host cell. 
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It has also been suggested that the gC and gB glycopro-
teins are involved in viral attachment to the host cells 
(15,59). 
After penetration, the nucleocapsid is transported 
through the cytoplasm and the viral DNA is released into 
the nucleus (1). Transcription of the viral DNA occurs in 
the nucleus, and viral proteins are synthesized in the 
cytoplasm (1,8). The immediate-early (IE) genes, the 
first genes to be expressed, are transcribed by the host 
enzyme RNA polymerase II (61). The IE proteins stimulate 
the transcription of other viral genes which encode the 
early (E) proteins (61,62). The IE genes are also self-
regulated (63). Some IE proteins may bind to the promot-
ers of the IE genes, thereby inhibiting their transcrip-
tion (63). In addition, some E proteins are also involved 
in inhibiting IE gene transcription (63). Most of the 
viral E proteins are involved in replication of the viral 
DNA, such as the viral DNA polymerase and thymidine kinase 
(61). Other E proteins function to stimulate transcrip-
tion of late (L) genes expressed after viral DNA replica-
tion (62,63). L proteins are primarily viral structural 
components such as capsid proteins and viral glycoproteins 
(62). Some L proteins are also involved in inhibiting 
transcription of E genes (63). Since some E and L pro-
teins are synthesized at the relatively early times folow-
ing infection (62,63,64,65), the designation of a, B, andY 
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genes has been widely used in herpesvirus research instead 
of the designations of IE, E and L genes (64,65). Follow-
ing nucleocapsid assembly in the nucleus, the envelope is 
obtained when the nucleocapsid buds through the inner 
nuclear membrane of the host cell (27). Mature virions 
accumulate in the membrane systems of the host cell, and 
may be released slowly by vacuolar membrane fusion and 
exocytosis or by lysis of the infected cells (21,27). 
As a result of herpesvirus infection, both nonspecif-
ic and specific immune responses are induced against the 
virus and infected cells (71,66,67). The nonspecific 
immune response involves not only production of high 
levels of interferon (IFN-a, IFN-B, IFN-f), but activation 
of macrophage, neutrophile, and NK cells as well (71). 
Macrophage and neutrophile mediate cytotoxicity of virus-
infected cells by binding the Fe region of anti-viral 
antibodies bound to infected cells (71,41,42). In the 
specific immune response, both humoral and cell-mediated 
immune mechanisms are involved (66,67). Both neutralizing 
and non-neutralizing antibodies are induced as a result of 
herpesvirus infection and neutralizing antibodies are 
directed against the viral glycoproteins (67,68,69). It 
has been shown that neutralizing antibodies are directed 
against and bind to epitopes on gB, gD, gC, and gG glyco-
proteins allowing antibody-dependent cellular cytotoxic 
(ADCC) and antibody-dependent complement-mediated cytotox-
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icity (ADCMC) processes to occur (69,70,71). 
The gE glycoprotein 
Over twenty years ago, it was observed that HSV1 in-
fected cells and virions could agglutinate sheep erythro-
cytes coated with rabbit anti-sheep erythrocyte antibodies 
(29). In addition, nonimmune rabbit IgG exhibited in-
creased binding to HSV-infected over uninfected cells 
(29,30). Hemadsorption and IgG binding were also demon-
strated to occur with cells infected by human CMV and VZV 
(31,32). Further study showed that the F(ab')2 fragment 
produced by pepsin digestion of IgG bound to infected 
cells much less than intact IgG, suggesting that IgG 
binding is associated with the Fe region (30). 
The IgG Fe receptor induced in cells following HSV 
infection could be encoded either by the host cell or by 
the virus. At intervals of addition of actinomycin D to 
the HSV1 infected cells resulted in a relative decrease in 
the amount of IgG bound to cells in the infective late 
stage by comparing with that in the infected cells of no 
addition of actinomycin D (30). This further supports the 
idea that the Fe receptor is encoded by the virus genome 
(30). It has also been shown that the Fe receptor is 
glycosylated (33). A [ 14c]-glucosamine-labeling polypep-
tide extracted from HSV1 infected cells was bound to IgG-
Sepharose columns and this glycoprotein had the same 
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electrophoretic mobility as that of [ 35s)-methionine-
labeled IgG binding proteins (33). Since this was the 
fifth glycoprotein identified in HSV1-infected cells, it 
was designated gE {33). 
Although HSV1 and HSV2 encode antigenically related 
Fe receptors, both vary in size based on SDS-PAGE analysis 
(34). Virus-specific monoclonal antibodies against the 
HSV1 and HSV2 gEs were used to identify which gE gene was 
present in various HSV1xHSV2 recombinant viruses (34,35). 
These studies mapped the position of the Fe receptor (gE) 
gene to the s region of the HSV genome {34,35). 
The length of unique sequences of the s region (Us) 
of HSV1 is about 13 Kbp (37). The s region contains 12 
genes based on mRNA mapping and DNA sequencing studies 
(36,37). To precisely map the gE gene, gE mRNA was iso-
lated using gE monoclonal or monospecific antibodies to 
immunoprecipitate polyribosomes actively translating the 
gE polypeptide in vitro (36). By hybridization of gE mRNA 
to DNA subfragments of the Us region, it was determined 
that gE gene is located between map coordinates 0.924 to 
0.951 (36). From DNA sequencing, it was further deter-
mined that the length of the gE open reading frame (ORF) 
is 1650 bp (37). Computer analysis of the predicted amino 
acid sequence of the gE gene revealed that gE has features 
typical of membrane proteins. These features include a 
signal sequence composed mostly of hydrophobic amino acids 
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near the N-terminus, a hydrophilic extra-cellular domain, 
an a-helical hydrophobic transmembrane region composed 
mostly of hydrophobic amino acids, and an internal cyto-
plasmic tail at the c-terminus. The exact three-dimen-
sional structure has not been determined. 
The function of the IgG Fe receptor (gE) in the 
infected cell membrane is not known completely (30). It 
has been suggested that it may serve to interfere with 
immune attack by the host, since aggregated HSV-immune 
rabbit IgG on HSV1 infected cells inhibits both ADCC and 
ADCMC activities in vitro (39). Recent studies have shown 
that HSV infected cells and virions may evade immune 
cytolysis when the Fe region of anti-viral IgG is bound by 
gE glycoprotein (38). In other words, the F(ab') region 
of immune IgG binds to its target glycoprotein (gB, gC or 
gD) while CH3 portion of Fe region of the IgG is bound by 
the gE glycoprotein (38,40). In this way binding of C1q 
to CH2 portion of Fe region of the immune IgG, the first 
step of activation of classical complement pathway, is 
inhibited due to steric restriction (38). Consequently, 
activation of the classical complement pathway by anti-
viral IgG is greatly inhibited (38,41). The ADCC process 
may be similarly inhibited, since the gE glycoprotein may 
compete with cytotoxic cells for binding of the Fe region 
of anti-viral antibodies (41). 
In addition to its ability to bind IgG Fe, the gE 
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glycoprotein may also be involved in induction of cell 
fusion (42). It has been demonstrated that the gB glyco-
protein is responsible for penetration of the virion into 
host cells by inducing fusion of the virion envelope with 
the cell plasma membrane (43). Both gD and gH have also 
been suggested to have a role in the fusion process 
(44,45). Recently it was found that monoclonal antibodies 
against gE inhibit multinucleate cell formation following 
HSVl infection, suggesting that gE is involved in syncyti-
um formation (42). However, the significance of the 
apparent fusion activity of gE glycoprotein remains un-
known at present (42). 
Although gE has been identified as the Fe receptor on 
HSV-infected cells, another glycoprotein (gi) forms a com-
plex with gE. Formation of this gE-gi complex is neces-
sary for Fe receptor activity (46). Mutation of gi has 
been shown to greatly decrease the ability of gE to bind 
the Fe region of antiviral IgG in vitro (46,42). It is of 
interest that gi itself does not bind Fe region of IgG at 
all (46). However, the exact role of gi in the gi-gE 
complex has not been established so far. 
Simian herpesvirus SA8 
Simian herpesvirus SAS, an a-herpesvirus indigenous 
to African monkeys, causes asymptomatic or oro-genital 
infections in its natural host species (4,47). SA8 has 
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also been associated with stillbirths and congenital 
abnormalities in baboon breeding colonies (48,50). Unlike 
B virus, the pathogenic potential of SA8 for human beings 
is unknown (4,47,49). As an a-herpesvirus, SA8 has a 
rapid replication cycle and characteristically induces 
syncytium formation following infection (4). Previous 
serological studies have shown that SA8 is very closely 
related to HSV1 and HSV2 (55,56,83). DNA sequencing 
studies have shown that several genes of SA8 have signifi-
cant homology to analogous genes of HSV1 (81). 
Purpose of the study 
Since SA8 is evolutionarily intermediate between HSV 
and other a-herpesvirus of lower mammals for which gE gene 
homologs have been identified and sequenced (54,53,52,51), 
identification and sequencing of the entire gE gene of SA8 
could be of value in studies on the molecular evolution of 
the herpesviruses. The goals of this study are 1) to 
determine if SA8 has a homolog of the HSV1 gE gene; 2) to 
locate the position of this gene in the SA8 genome; and 3) 
to clone and sequence the SA8 gE gene homolog. 
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CHAPTER II 
MATERIALS AND METHODS 
Experimental Approach 
The BamHI D fragment (10 Kbp) which contains most of 
the Us region of the SAB genome was already cloned into 
plasmid pUC19 in this laboratory (designated pSBD). To 
map and to subclone pSBD, the plasmid was first transfect-
ed into DH5a cells and grown on agar plates (72,75). 
Colonies were picked, grown up in liquid culture over-
night, and the plasmid DNA isolated by an alkaline lysis" 
miniprep" method (74). Plasmid DNAs were characterized by 
restriction enzyme digestion analysis on agarose gels 
(72}. Subcloning of restriction fragments was performed 
by shotgun cloning or electroelution of fragments from 
agarose gels, ligation into pUC19, and transfection into 
DH5a cells (73,72). The double stranded plasmid DNA used 
for sequencing template was purified by a modified mini-
prep method or by use of QIAGEN anion-exchange columns. 
DNAs were sequenced using a modified dideoxynucleotide 
chain-termination procedure (76,77). DNA sequence data 
were assembled and analyzed with the aid of a computer. 
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Specific Methods 
Plasmids and Cells 
E.coli DH5a cells (BRL, Gaithersburg, MD) were used 
for propagation of plasmids. Plasmid pUC19 (75) and pLH1 
(78) were used to clone all DNA fragments. pLH1 is the 
same plasmid as pUC19, differing only in the polylinker 
sequence. Both of these plasmids carry an ampicillin re-
sistance (Ampr) gene with ~he polylinker cloning sites 
located between the promoter and coding sequences of the 
B-galactosidase (B-gal) gene. Cloning of a foreign DNA 
fragment into these cloning sites results in inactivation 
of the B-gal gene. Recombinant plasmids can therefore be 
selected for by Ampr (only DH5a cells which have acquired 
the plasmid can grow in the presence of amplicillin) and 
X-gal (which when cleaved by the B-gal enzyme produces a 
blue color; bacterial colonies containing plasmids with a 
foreign DNA fragment appear white rather than blue). 
Tansformation of Plasmids into ~ coli 
Transformation-competent DH5a cells were prepared 
using a modified cac12 procedure (72). DH5a cells were 
grown in LB media overnight and 100 ul of this culture 
were inoculated into 10 ml LB broth to grow up until 
bacteria produced an apparent absorbance of 0.2 at 600 nm. 
After centrifugation the pellet was resuspended in 20 ml 
of transformation buffer (50 mM CaCL2 , 15% glycerol, 10 mM 
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MOPS, pH 6.6). After setting on ice 20 min, cells were 
pelleted and resuspended in 2 ml transformation buffer. 
Cells were then distributed in 100 ul aliquots (about 
6x106 cells) into 1.5 ml microfuge tubes, immersed briefly 
in liquid nitrogen (about 5 sec), and stored at -70°C. 
One microfuge tube of competent DH5a cells was used 
for each transformation. Cells were thawed at room tem-
perature and placed on ice for 30 min. The ligated plas-
mid-viral DNA (about 1 ug) was added to the bacteria and 
held on ice for 30 min. Cells were then heat shocked at 
37° c in a water bath for 2 min. 900 ul of prewarmed SOC 
media (2.5% LB base, 10 mM Mgso4 , 10 mM MgC12 , 20 mM 
glucose, pH 7.5) were added to the tube and incubated at 
37°C for about 45 mins. Aliquots of cells (150 ul) were 
plated on agar plates (1.5% Bacto-Agar in LB broth, 25 
ugjml ampicillin and 40 ugjml X-gal). The plates were 
inverted and incubated at 37° C about 16 hrs. 
Screening and Plasmid DNA Recovery 
Individual white colonies were picked from plates and 
grown up overnight in LB media containing 25 ugfml ampi-
cillin at 37°C with constant shaking. Plasmid DNA was 
isolated by an alkaline lysis miniprep method as follows 
(74): 1.5 ml of overnight bacterial culture was added to a 
microfuge tube and centrifuged in a microfuge (10,000 rpm) 
for 15 sec. The supernatant was removed and the tube 
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refilled with another 1.5 ml of the bacterial culture. 
This was then centrifuged and the supernatant again re-
moved. The pellet was resuspended in 100 ul of Solution I 
(50 mM glucose, 25 mM Tris, 10 mM EDTA, pH 7.5). After 5 
min at room temperature, 200 ul Solution II (0.2 N NaOH, 
1% SDS) was added, mixed by inversion, and put on ice for 
5 min. 150 ul cold Solution III ( 3 M KOAc, 11.5% glacial 
acetic acid) was then added, mixed by inverting gently and 
put on ice for 5 min. The bacterial chromosomal DNA was 
then precipitated and removed by centrifugation at 10,000 
rpm for 5 min. The plasmid DNA in the supernatant was 
then precipitated by adding an equal volume of isopropanol 
and centrifugation at 10,000 rpm for 15 min. The pellet 
was rinsed with 70% EtOH, dried, and resuspended in 
10T/0.1E buffer (10 mM Tris, 0.1 mM EDTA, pH 8.0). Since 
the activity of restriction enzymes could be affected by 
contaminating proteins in the DNA sample, the plasmid DNA 
was further purified by adding 1/2 volume NH4Ac (7.5 M), 
incubating on ice for 10 min, and centrifugation for 10 
min at 10,000 rpm. DNA in the supernatant was then pre-
cipitated by adding 2 volumes of cold 100% EtOH. After 
centrifugation, the DNA pellet was dried and resuspended 
in 10T/0.1E or distilled water. 
Restriction Enzyme Digestion 
For restriction enzyme analysis of DNA, 0.5-1.0 ug 
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samples of plasmid DNA were digested with 0.5-2.0 units of 
restriction enzyme in a 10-15 ul volume for about 1-2 hr 
at 37°C (72). If digestion with more than one enzyme was 
necessary, digestion with the enzyme requiring the lowest 
salt buffer was performed first, followed by digestion for 
an additional 1 hr with enzyme requiring a higher salt 
buffer (72). 
Gel Electrophoresis 
Agarose gels, usually between 0.6-1.2%, were made by 
dissolving agarose in Tris-acetate buffer [40 mM Tris-ace-
tate, 2 mM EDTA, pH 8.0; (TAE)] containing 10 ugfml EtBr 
by heating in a microwave oven (72). Prior to running on 
the gels, contaminating RNA in DNA samples was removed by 
addition of 0.5 ug RNase A together with tracking 
dye/glycerol to 2% final concentration. Samples were then 
run by electrophoresis in TAE buffer containing 10 ugfml 
EtBr at 60-110 volts, depending on the size of the DNA 
fragments. Phage DNA cut by EcoRI and by Hindiii+EcoRI 
was used as a size marker. The size of restriction frag-
ments was determined by visualization of DNA under ul-
traviolet light and determination of their mobility rela-
tive to the phage marker DNA. 
Subcloning of Restriction Fragments 
Restriction enzyme-digested DNA samples from which a 
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fragment was to be electroeluted were run on inhibitor-
free agarose gels (molecular biology grade, BioRad Labora-
tories; Richarrnond, CA) (72). After electrophoresis to 
separate DNA fragments, a gel plug containing the desired 
fragment was cut out of the gel and inserted into a dialy-
sis bag (72) with TAE buffer (without EtBr) and electro-
phoresed in TAE buffer (also without EtBr) for about 45 
min at 100 volts. The polarity was then reversed for 
about 10 sec, the gel removed from the dialysis tubing, 
and the buffer containing the DNA fragment collected. 
Plasmid DNA which had been previously digested with the 
appropriate restriction enzyme was added to the electroe-
luted DNA fragment, both DNAs were co-precipitated by 
NH4Ac/EtOH precipitation as described above, and the 
pellet resuspended in 17.5 ul distilled water. Where 
restriction fragments were shotgun cloned, the parent 
plasmid DNA and vector DNA were mixed and digested with 
0.5-2.0 units restriction enzyme for 2 hr at 37°C followed 
by NH4AcjEtOH precipitation, and the DNA resuspended in 
17.5 ul distilled water. 
For ligation of inserts into plasmid DNA, 2 ul lOx 
ligase buffer and 0.5 ul (1.5 U) T4 ligase (Promega Bio-
tech, Madison, WI) were added, mixed, and put at 4°C 
overnight. The following day the DNA ligation mixture was 
transfected into DH5a cells and plated on Arnp-Xgal agar as 
described above. Colonies were picked and grown up in 3.5 
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ml LB media with 25 ugjml ampicillin. Plasmid DNA was 
isolated by the miniprep method described above and 
checked with the appropriate restriction enzymes to con-
firm that the plasmid contained a single copy of the 
desired restriction fragment. 
DH5a cells carrying plasmids were prepared for long 
term storage as follows: 700 ul of an overnight liquid 
culture were transferred to a sterile microfuge tube and 
300 ul of sterile 50% glycerol added. These were mixed 
and stored at -70°C. All cell lines were frozen in trip-
licate. All the clones and subclones produced and used in 
this study are shown in Figure 2. 
DNA Seguence Analysis 
Double stranded template DNA was isolated from 20 ml 
overnight cultures using the miniprep method described 
above. DNA was then further purified by treatment with 
RNase A for 10 min at 37°C and precipitated with NH4Ac 
/EtOH. Double stranded plasmid DNA templates were also 
purified from 100 ml overnight cultures by passing the 
product of an alkaline lysis procedure over a QIAGEN 
anion-exchange column (QIAGEN Inc., Chatsworth, CA). The 
DNA was then recovered by EtOH precipitation. About 4 ug 
template DNA was denatured in 0.4 M NaOH/4 mM EDTA for 5 
min, neutralized by adding NH4Ac to a final concentration 
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DNA was rinsed with 70% EtOH and dried. 
Sequencing gels (18x40 em) of 6.0%-7.5% acrylamide 
containing 9 M urea were cross-linked with bis using ammo-
nium persulfate (25 mgjml) and TEMED. The gel solution 
was added to the gel unit with a syringe while held at a 
45° angle. The gel was allowed to polymerize with the 
unit laying flat for at least 1 hr. Gels were pre-elec-
trophoresed for 1 hr at 1600 volts. All gels were run in 
Tris-borate buffer (working solution: 89 mM Tris-borate, 
89 mM boric acid, 2 mM EDTA, pH 8.3). 
The high G+C content of SA8 DNA presented problems in 
sequencing the gE gene. A high G+C content often causes 
problems due to formation of secondary structures in the 
template DNA. This can result in poor annealling of 
primers with the template DNA, band compression on gels, 
and lack of fidelity of sequence product in these regions. 
Since a high reaction temperature will help prevent sec-
ondary structure formation, a modified dideoxynucleotide 
chain termination reaction was used (79,77). First, the 
Taq polymerase was used for DNA sequencing. The Taq DNA 
polymerase isolated from Thermus aquaticus is thermostable 
up to 95°C, allowing sequencing to be carried out at 56-
600C rather than the usually 37°C. Second, 7-deaza dGTP 
was used in place of dGTP in all sequencing reaction to 
help alleviate band compression caused by self annealing 
of product DNAs, particularly when the ends have a high 
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G+C content. 
Universal pUC/M13 forward and reverse primers (24 
mers) were purchased from Promega Biotech (Madison, WI). 
synthetic primers (24 mers) complementary to SA8 sequences 
were purchased from National Biosciences, Inc. (Hamel, 
MN). Primers were annealed with template DNA at 56°C for 
10 min in 5x sequencing buffer (500 mM Tris-HCl, 100 mM 
Mgcl2 , 50 mM DTT, 1.0 mM spermidine, pH 7.5) and 7.5 uM 
each of dGTP,dTTP, and dCTP. 2 ul a-[ 32P]-dATP (20 uCi) 
and 1.5 ul Taq polymerase (0.75 u) were added and DNA 
synthesis extension carried out at 56°C for about 5 min. 
Aliquots of 1 ul of this extension mixture were then 
transferred to four microfuge tubes each containing one of 
the four different deoxyjdideoxy nucleotide mixtures. The 
termination reaction was then allowed to proceed for 15 
min at 65°C. In some instances, reaction products were 
tailed using terminal deoxynucleotide transferase for 30 
min at 37°C. All reactions were stopped by addition of 
stop solution (10 mM NaOH, 95% formamide, 0.05% bromophe-
nol blue, 0.05% xylene cyanole). Samples were heated at 
100°C for 5 min immediately before loading on sequencing 
gels. Samples were usually loaded at multiple times to 
obtain maximal sequence information from each sequencing 
reaction. Sequencing gels were run at a constant voltage 
of 1600 volts. After electrophoresis, gels were trans-
ferred to Whatman 3 mm filter paper and dried at ao0 c 
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under vacuum for 30 min. DNA sequencing products were 
detected by autoradiography on Kodak XAR film for 1-18 
hrs. 
DNA sequence data were recorded and assembled on a PC 
using the IBI Pustell DNA analysis programs. These pro-
grams were also used for DNA homology searches (80). The 
UWGCG programs running on a VAX 6320 were used to predict 
and analyze amino acid sequences. The MULTALIN program of 
Corpet (81) was used for multiple sequence alignment and 




The BamHI D fragment of SA8 viral DNA had previously 
been mapped to the short region of the genome and was pre-
sumed to comprise most of the Us region of SA8. A number 
of subclones of this 10 Kbp fragment were made using Kpni, 
Sal!, SmaijXmai, and EcoRI (Figure 2). End sequencing of 
a number of these cloned fragments yielded several hundred 
base pairs of DNA sequence each. A computer search was 
made for homology with sequences in the Us region of HSVl 
using the IBI Pustell DNA analysis programs. Several 
regions of the SA8 BamHI D fragment were found to have 
good homology with genes in the HSVl Us region. These 
regions of homology were located in the US3, US6(gD), 
US7(gi), usa (gE) and USlO genes of HSVl. Comparison of 
the distances between these homologous sequences in HSVl 
(based on sequences data; 37) and SA8 (based on size 
estimates of cloned restriction fragments as determined by 
agarose gel electrophoresis) indicated that distances 
between the regions of homology were similar in the two 
viruses (Figure 3). These results imply that 1) the order 
and orientation of these five genes are the same in SA8 as 
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present in the SA8 Us region relative to the HSV1 Us 
region. 
Since the SA8 Kpni L fragment (pSKL) and the adjacent 
BamHI-Kpni fragment (pSBD1) both had good homology with 
the gE gene of HSV1, a number of subclones were made of 
these two fragments (Figure 2). Subclones spanning the 
two adjacent Kpni sites within the gE gene were completely 
sequenced on both strands utilizing both universal pUC/M13 
primers and synthetic primers. The entire gE sequence of 
SA8 was assembled based on overlapping sequences and, to a 
lesser extent, on alignment with the HSV1 gE sequence. 
The complete DNA sequence of SA8 gE ORF and flanking non-
coding sequences is shown in Figure 4. The SA8 gE ORF was 
1602 nucleotides in length and had a base composition of 
76.2% G+C. This compares to the 1650 nucleotide gE ORF of 
HSV1 which has a 66.6% G+C (37). The predicted amino acid 
sequence of the SA8 gE gene product is 534 residues in 
length as compared to the 550 amino acid HSV1 gE polypep-
tide. 
Alignment of the SA8 gE ORF sequence with the HSV1 gE 
ORF indicated that the DNA sequence had 58% homology. 
Figure 5 shows the predicted SA8 gE amino acid sequence 
aligned with the HSV1 gE sequence. It was necessary to 
introduce gaps into SA8 and HSV1 sequences in order to 
obtain maximal alignment. The introduced gaps occur 
mostly in the N- and c-terminal regions of the polypep-
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10 20 30 40 50 60 70 
* * * * * * * * * * * * * * * 
CGGAACGCGCGCGTAGGCAGGCTGCGCGGGCCTATTAAGGCCGCGGCCGGCCGGCGTCTTCGCGTTCCGAACGCCCGGT 
90 100 110 120 130 140 150 
* * * * * * * * * * * * * * * * 
GGATCGTTCCCCGCTCCGGTCGCTAGCGACGCGCCCGTGGCCAGGAAGAGGGGAGACGACGAGAAGCGGGG ATG GCT 
Met Ala 
160 170 180 190 200 210 
* * * * * * * * * * * * 
CTC GCC CGG GCC CCG CGG GGG CTC CTG GCG GCG TGG ATT CTC GCG GCG TGG GTC GGC GTC 
Leu Ala Arg Ala Pro Arg Gly Leu Leu Ala Ala Trp Ile Leu Ala Ala Trp Val Gly Val 
N 220 230 240 250 260 270 
00 * * * * * * * * * * * * 
GCG GCC GTG GAG ACG ACG TGG AAG CAC GCG AGC GCC GGC GAC GAC GTG GTG TTC TTC GTC 
Ala Ala Val Glu Thr Thr Trp Lys His Ala Ser Ala Gly Asp Asp Val Val Phe Phe Val 
280 290 300 310 320 330 
* * * * * * * * * * * * 
CTT CCC GCG GGG CGC CCG GGC GGA CCC CCG CGC GAG CTG GCG TGG GAG TTC GCT TCT ATG 
Leu Pro Ala Gly Arg Pro Gly Gly Pro Pro Arg Glu Leu Ala Trp Glu Phe Ala Ser Met 
340 350 360 370 380 390 
* * * * * * * * * * * * 
CGG AAC TGC GGG CCG CTG CGG CCG TCG TGG GTC TCC CTC CAC CCC CCC GGG CAG GTG CTG 
Arg Asn Cys Gly Pro Leu Arg Pro Ser Trp Val ser Leu His Pro Pro Gly Gln Val Leu 
N 
1.0 
400 410 420 430 440 450 
* * * * * * * * * * * * 
GAG ACC GTC GTC GAC GCC CAG TGC GTC GGC GCC CCC CCG GTT CAT GGC GGC GTG GTA CGG 
Glu Thr Val Val Asp Ala Gln Cys Val Gly Ala Pro Pro Val His Gly Gly Val Val Arg 
460 470 480 490 500 510 
* * * * * * * * * * * * CCG ACC CGA CGG GGC CCC CGC CCC GGG CCC CGA GGC GGC GTG GCC CCC GCG CGT GAC GTG 
Pro Thr Arg Arg Gly Pro Arg Pro Gly Pro Arg Gly Gly Val Ala Pro Ala Arg Asp Val 
520 530 540 550 560 570 
* * * * * * * * * * * * AGC AAC GGG ACG CTG ACG CTC CGC GAG GCC CGA CCG AGC GAC AGC GGG ATG TAC GTC CTG 
Ser Asn Gly Thr Leu Thr Leu Arg Glu Ala Arg Pro Ser Asp Ser Gly Met Tyr Val Leu 
580 590 600 610 620 630 
* * * * * * * * * * * * ACG GTG TCG CGC GCC CCC AAC TCC ACG GCG GCC CGT CGG GTG GTG TTC CTG ACC GTC GGG 
Thr Val Ser Arg Ala Pro Asn Ser Thr Ala Ala Arg Arg Val Val Phe Leu Thr Val Gly 
640 650 660 670 680 690 
* * * * * * * * * * * * CCG CGG GTC GCG GCG GCG GTC CCC GGC GGC CCG CCC CCT CTC GCG GAG GGG GCG GGA GCC 
Pro Arg Val Ala Ala Ala Val Pro Gly Gly Pro Pro Pro Leu Ala Glu Gly Ala Gly Ala 
700 710 720 730 740 750 
* * * * * * * * * * * * GAG GCC GGG GCC GCC GCG ACC CGG GCC CCC GCC GCC CAC CCC TAC CCC CAC CCC CAC CCC 









790 800 810 
* * * * * * ATC GCC GAG GTG GCG CAC GTG CAC GGC GTC ACG GTC TCC CTG CGC ACC CAG ACG GCG ATC 
Ile Ala Glu Val Ala His Val His Gly Val Thr Val Ser Leu Arg Thr Gln Thr Ala Ile 
820 830 840 850 860 870 
* * * * * * * * * * * * CTG TTT AGC CCG GGG GAC ACC GTC CAC ACC GCG GTC TCC ATC GTG CCG TTC GCC CAC GAC 
Leu Phe Ser Pro Gly Asp Thr Val His Thr Ala Val Ser Ile Val Pro Phe Ala His Asp 
880 890 900 910 920 930 
* * * * * * * * * * * * GAC GAC CCC TAC GTC ATG GAG GTG GTC TGG GTG CGG TTC GAC GTC CCC GAG GAG TGC GGG 
Asp Asp Pro Tyr Val Met Glu Val Val Trp Val Arg Phe Asp Val Pro Glu Glu Cys Gly 
940 950 960 970 980 990 
* * * * * * * * * * * * GAG ATG CGG ATC TAC GAG CCC TGC CTG TAC CAC CCG CGG CTG CCC GAG TGC CGC TCG CCC 
Glu Met Arg Ile Tyr Glu Pro cys Leu Tyr His Pro Arg Leu Pro Glu Cys Arg Ser Pro 
1000 1010 1020 1030 1040 1050 
* * * * * * * * * * * * 
GCC GAC GCC CCG TGC GCG GCA AGC GTC TGG ACG GAG CGC CTG GCA GTG CGG CGG TAC GGG 
Ala Asp Ala Pro Cys Ala Ala Ser Val Trp Thr Glu Arg Leu Ala Val Arg Arg Tyr Gly 
1060 1070 1080 1090 1100 1110 
* * * * * * * * * * * * 
CCC TGC TCG CGC CAC GTG CCG CCC CCC CGG TGC CCC ACG GAC GCC GCC ATG GAG GCC AGG 
Pro Cys Ser Arg His Val Pro Pro Pro Arg Cys Pro Thr Asp Ala Ala Met Glu Ala Arg 
w 
f-' 
1120 1130 1140 1150 1160 1170 
* * * * * * * * * * * * CCC GGC CTG GGG TGG TAC GGG CCC ACC GTT AAC CTG CAG CTC CGC GAC GCC TCC GAG GCG 
Pro Gly Leu Gly Trp Tyr Gly Pro Thr Val Asn Leu Gln Leu Arg Asp Ala Ser Glu Ala 
1180 1190 1200 1210 1220 1230 
* * * * * * * * * * * * AGC GGC GGG CTC TAC GTG TGC GTC GTG TAC GTC AAC GGG CAC GTG CAC GCC TGG GGC CAC 
Ser Gly Gly Leu Tyr Val Cys Val Val Tyr Val Asn Gly His Val His Ala Trp Gly His 
1240 1250 1260 1270 1280 1290 
* * * * * * * * * * * * GTC GTC GTC AGC ACC GCG GCG AGG TAC CGG AAC GCG GTC GTG GAG CGG TCC CTG CCG CGG 
Val Val Val Ser Thr Ala Ala Arg Tyr Arg Asn Ala Val Val Glu Arg Ser Leu Pro Arg 
1300 1310 1320 1330 1340 1350 
* * * * * * * * * * * * TAC CGC CCC CCT CCG GCC GCA CCC ACC CCT TCG GCG CGG CCC CAG GGG CCG CCC GCG CTC 
Tyr Arg Pro Pro Pro Ala Ala Pro Thr Pro Ser Ala Arg Pro Gln Gly Pro Pro Ala Leu 
1360 1370 1380 1390 1400 1410 
* * * * * * * * * * * * 
CGC TCG CCG CGC CTC GTG GGC GTC TTC GGC GCG GCC CTG GGG CTG GCC GCC GCC GGC CTC 
Arg Ser Pro Arg Leu Val Gly Val Phe Gly Ala Ala Leu Gly Leu Ala Ala Ala Gly Leu 
1420 1430 1440 1450 1460 1470 
* * * * * * * * * * * * TCC GTG TGG GCC TGC GTC ACC TGC CGG CGC GCG CGG GCG TGG CGA GCC GTT AAA AAG CGG 
Ser Val Trp Ala Cys Val Thr Cys Arg Arg Ala Arg Ala Trp Arg Ala Val Lys Lys Arg 
1480 1490 1500 1510 1520 1530 
* * * * * * * * * * * * GAC CCG GGA ACG CAG ACT TAC ATT CGC CTG GCG GAC GAC GAG CTC TAC GCC GAC CTG AGC 
Asp Pro Gly Thr Gln Thr Tyr Ile Arg Leu Ala Asp Asp Glu Leu Tyr Ala Asp Leu Ser 
1540 1550 1560 1570 1580 1590 
* * * * * * * * * * * * TCC GAC GGC GGC TGG GAG GAC TCC GAG GAC GAC GAC TCC GAC GAC GAC CGC CTG CCG GGA 
Ser Asp Gly Gly Trp Glu Asp Ser Glu Asp Asp Asp Ser Asp Asp Asp Arg Leu Pro Gly 
1600 1610 1620 1630 1640 1650 
* * * * * * * * * * * * ACG GAC CGG CCT CCG AAG CGG GGC TCC GGG TTC CAG ATC CTC TCC GGG ACG AAG GCG GAC 
Thr Asp Arg Pro Pro Lys Arg Gly Ser Gly Phe Gln Ile Leu Ser Gly Thr Lys Ala Asp 
1660 1670 1680 1690 1700 1710 
* * * * * * * * * * * * CCG TGG TCC CCC GAG GCG CGC CGG GGC CGC GAC CTC GTC ACC TTC CGC GTG GAT GAC GCG 
w Pro Trp Ser Pro Glu Ala Arg Arg Gly Arg Asp Leu Val Thr Phe Arg Val Asp Asp Ala 1:\.) 
1720 1730 1740 1750 1760 1770 
* * * * * * * * * * * * GCC AGA TAT CGC GAC GCC TCG CCC CCC GAT CCA CCG CAC CGG CGC TGA CGCCCGTGCGCGGGC 
Ala Arg Tyr Arg Asp Ala Ser Pro Pro Asp Pro Pro His Arg Arg 
1790 1800 1810 1820 1830 1840 1850 
* * * * * * * * * * * * * * * * 
CCGAGGCGCCCGACGTTCCCATCGGCGTCGCCGAAGACCTGCGGGCCCTCGCAAGTACGTGCCGCGCCGCGCGCGCGCT 
1870 1880 1890 1900 
* * * * * * * * * CCGCCGTCGGCCCCGCCGCCCCTCCCCCTGGAGGCGGTCGAC 
tides. Based on this alignment, the SA8 and HSV1 gE amino 
acid sequences are 49.1% identical (based on the percent 
of positions where the same amino acid occurs in the same 
position in both sequences). When conservative amino acid 
substitutions are taken in consideration, the SA8 and HSV1 
gE sequence are 64.7% identical andjor similar. 
Several parameters of the predicted secondary struc-
ture of SA8 and HSV1 gE polypeptides generated using UWGCG 
programs PEPTIDESTRUCTURE\PLOTSTRUCTURE are shown in 
Figure 6. Plots are shown for the hydrophilicity and the 
occurrence of a-helices, B-sheets, and B-turns in both 
polypeptides. Prediction of secondary structural features 
for the SA8 gE indicate that the polypeptide has a number 
of properties typical of membrane proteins. These include 
a short strongly hydrophobic region at the N-terminus, a 
long hydrophilic region which has 2 potential sites for 
addition of N-linked carbohydrate residues, a hydrophobic 
region of about 20-25 amino acids near the C-terminus 
which could serve as a transmembrane anchor sequence, and 
a charged hydrophilic c-terminus. 
The N-terminal hydrophobic region has a stretch of 21 
hydrophobic amino acids which probably serves as a mem-
brane insertion signal. This hydrophobic core region is 
preceded by a positively charged residue (Arg8 ) and is 
terminated by another positively charged residue (Lys 30 ). 
Two potential sites for cleavage of the signal peptide 
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1 ••... MDRGAVVGFLLGVCVVSCLAGTPKTSWRRVSVGEDVSLLPAPGPT 45 
-II :.:::1:. I· ·=···1·1==·1·1=11 ::. I=· 
1 MALARAPRGLLAAWILAAWVG .•. VAAVETTWKHASAGDDVVFFVLPAGR 47 
46 GRGPTQKLLWAVEPLDGCGPLHPSWVSLMPPKQVPETVVDAACMRAPVPL 95 
• 11···1 I····= ·1111=111111 II II 111111·1= II·· 
48 PGGPPRELAWEFASMRNCGPLRPSWVSLHPPGQVLETVVDAQCVGAPPVH 97 
96 AMAYAPPAPSATGGLRTDFVWQERAAVVNRSLVIHGVRETDSGLYTLSVG 145 
• • I·.:: ·I I·=· ·I I ·1·===·1··111=1·1·1= 
98 GGVVRPTRRGPRPGPRGGV .• APARDVSNGTLTLREARPSDSGMYVLTVS 145 
146 DIKDPARQVASVVLVVQP •.• APVPTPPPTPADYDEDDNDEGEDESLAGT 192 
1·1·1·1 1=11··11· I= =·I·=·= 1=1 . . . . . . 
146 RAPNSTAARRVVFLTVGPRVAAAVPGGPPPLAE ...... GAGAEAGAAAT 189 
193 PASGTPRLPPPPAPPRSWPSAPEVSHVRGVTVRMETPEAILFSPGETFST 242 
·1·=····1·1·= =11·11=1111·= 1··1111111=1· I 
190 RAPAAHPYPHPHP .•.••.. IAEVAHVHGVTVSLRTQTAILFSPGDTVHT 232 
243 NVSIHAIAHDDQTYSMDVVWLRFDVPTSCAEMRIYESCLYHPQLPECLSP 292 
-Ill ::1111=·1 1=111=11111-·1=111111·11111·1111 II 
233 AVSIVPFAHDDDPYVMEVVWVRFDVPEECGEMRIYEPCLYHPRLPECRSP 282 
293 ADAPCAASTWTSRLAVRSYAGCSRTNPPPRCSAEAHMEPVPGLAWQAASV 342 
11111111·11·11111-1=·111 11111··=1 II= 111=1 ::.1 
283 ADAPCAASVWTERLAVRRYGPCSRHVPPPRCPTDAAMEARPGLGWYGPTV 332 
343 NLEFRDASPQHSGLYLCVVYVNDHIHAWGHITISTAAQYRNAVVEQPLPQ 392 
II:: 1111·· :Ill: 111111: I: IIIII :.: 1111-1111111··11· 
333 NLQLRDASEASGGLYVCVVYVNGHVHAWGHVVVSTAARYRNAVVERSLPR 382 
393 RGADLAEPTHPHVGAPPHAPPTHGALRLGAVMGAALLLSALGLSVWACMT 442 
:. 1·11·· :I :I· • 11·=1=1111 1·1 1111111=1 
383 YRPPPAAPTPS .. ARPQGPRPALRSPRLVGVFGAALGLAAAGLSVWACVT 430 
443 CWRRRAWRAVKSRASGKGPTYIRVAYSELYADWSS ....• DSEGERDQVP 487 
1=1 1111111·1··1 ··1111=1 ·11111=11 Ill::.:. 
431 CRRARAWRAVKKRDPG.TQTYIRLADDELYADLSSDGGWEDSEDDDSDDD 479 
488 WLAPPERPDSPSTNGSGFEILSPTAPSVYPRSDGHQSRRQLTTFGSGRPD 537 
:1: •• :1 1···1111=111·1 :. 1=1·= •. 1=1·11 : :. 
480 RLPGTDR ••• PPKRGSGFQILSGTKAD •. PWSPEARRGRDLVTFRVDDAA 524 
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occur following the hydrophobic core sequence. One site 
is located at Ala32-ser33 -Ala34 and the other at Leu43 -
Pro44-Ala45. The first potential cleavage site at Ala 34 
is four residues from the end of the hydrophobic core 
sequence. The second potential site at Ala45 is situated 
within a predicted B-turn structure resulting from the 
presence of Pro residues at positions 44 and 48. The 
peptide Ala-X-Ala is the most frequent sequence for poten-
tial cleavage and an Ala at position +4 is one of the most 
frequent residues for peptidase cleavage (82). The 
presence of a Pro in the second potential site mostly 
reduces the probability of peptidase cleavage (82). 
Therefore the sequence Ala32-ser33 -Ala34 is favored as the 
probably site for cleavage of the SA8 gE signal peptide. 
This is similar to that of HSV1 gE in which the leader 
sequence is predicted to be cleaved at c-terminal of the 
Val 32 residue (37). 
The external hydrophilic region extends from SA8 gE 
amino acids 30 to 401. The c-terminal part of this region 
has strong homology with the HSV1 gE sequence (from HSV1 
residues 214 to 414; see Figure 5). In this region the 
two polypeptides are 63% identical to each other. Intro-
duction of only 1 gap was necessary to achieve maximal 
alignment of the sequences in this region. Of the seven 
Cys residues in this region of HSV1 gE, all are conserved 
in SA8. In addition, predicted secondary structural 
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features such as a-helices and B-sheets are also very 
similar in this region of the two polypeptides (Figure 6) . 
Two potential N-linked glycosylation sites (Asn-Xxx-
Ser/Thr) are present in the gE polypeptides of both SA8 
and HSV1. One of these is conserved while the other is 
located at a different but close site in the two polypep-
tides. These results imply that a substantial part of the 
extracellular domain of the SA8 gE is structurally very 
similar to that of the HSV1 gE polypeptide. 
The region from amino acids 407-428 of the SA8 gE 
polypeptide is composed primarily of hydrophobic nonpolar 
amino acids and has good homology with the corresponding 
region of the HSV1 gE polypeptide (from amino acids 420-
440). The predicted strong a-helical structure in this 
region of both viral gE polypeptides (Figure 6) supports 
the idea that this region of the SA8 gE polypeptide repre-
sent the transmembrane domain which may also serves to 
anchor the cell membrane. 
The HSV1 and SA8 gE c-terminii are predicted to 
extend from the cell membrane into the cell cytoplasm. 
Both the HSV1 and SA8 gE cytoplasmic tails are highly 
charged and hydrophilic. Both are also the same size (110 
amino acids). However, there is limited sequence homology 
between the two peptides in this region, particulary at 
the extreme c-terminus. These results imply that this 
region may be 1) unimportant (non-functional), 2) involved 
37 
in altogether different functions in the two viruses, or 
3) serves a common function in the two viruses but does so 
in some virus-specific manner (such as interaction with 
non-conserved viral proteins) . 
Since the SA8 gE amino acid sequence has significant 
homology with its HSV1 homolog, a multiple alignment of 
the SA8 gE amino acid sequence with that of other a-her-
pesvirus (PRV, VZV, EHV1, and part of EHV4, and HSV2) gE 
amino acid sequences (51,52,53,54) was made (Figure 7). 
The published VZV gE ORF was about 120 amino acid residues 
longer than all the other gE sequences which presented 
problems in performing multiple alignments. Since an 
internal Met residue at position of 120 of the VZV gE 
could possibly serve as an alternative initiation site, 
the N-terminal 119 amino acids were removed from the VZV 
gE sequence for alignment. 
The multiple alignment of the seven gE sequences 
revealed that the region of the extracellular domain 
proximal to the transmembrane region was fairly conserved 
among all of these viruses. That the seven Cys residues 
in this region are all conserved in the SA8 and HSV1 gEs 
has already been described. six of these seven Cys resi-
dues are also conserved in PRV, VZV, EHV1. These results 
further demonstrate the conserved structure of this region 
of the gE polypeptide. 
















1 10 20 30 40 50 60 
MA •. RGAGLVFFVGVWVVSCLAAAP •. RTSWKRVTSGEDVVLLPAPAERTRA .. HKLLWAAEPLDACGPL 
* *** * ** ****** * *** ** **** ***** * ***** **** **** 
MD .. RGAVVGFLLGVCVVSCLAGTP .. KTSWRRVSVGEDVSLLPAPGPTGRGPTQKLLWAVEPLDGCGPL 
* ** * * * * * ** * ** * * **** 
MA •• LARAPRGLLAAWILAAWVGVAAVETTWKHASAGDDVVFFVLPAGRPGGPPRELAWEFASMRNCGPL 
* * ** * * MRPFLLRAAQLLALLALALSTEAPSLSAETTPGPVTEVPSPSAEVWDLSTEAGDDDLDGDLNGDDRRAGF 
* ** * * * * * * ME .. LLAASRACIFFGLVTVLDAWGVQQVE .••• LSEGAWAMIDGRDV .•..•...•... LTPTNTTTRV 
* * * * 
MS .. AQEDLGDDTGIHVIPTLNGDDRHKIV •.• NVDQRQYGDVFKGDLNPKPQGQPLIEVSVEENHPFTL 
70 80 90 100 110 120 130 
RPSWVAL .. WPPRRVLETVVDAACMRAPEPLAIAYSPPFPAGDEGLYSELAWRD .. RVAVVNESLVIYGA 
**** * ** * ************ *** ** ** * ** * * **** **** * 
HPSWVSL •• MPPKQVPETVVDAACMRAPVPLAMAYAPPAPSATGGLRTDFVWQE .. RAAVVNRSLVIHGV 
****** ** ** ****** * ** * * * * * * 
RPSWVSL .• HPPGQVLETVVDAQCVGAPPVHGGVVRPTRRGPRPGPRGGVA.PA .. RDVS.NGTLTLREA 
** ** * * ** ** * * * 
GSALASLREAPPAHLVNVSEGANFTLDARGDGAVVAGIWTFLPVRGCDAVAVTMVCFETACHPDLVLGRA 
* * * ** * * * * * * 
TKAWTFL.ETPPGCAGDISVKKVCVSHSLCEDNIIIGKHCNL.LTGEHGIALAE •. FNVVNGSLRRTDDV 
* * ** ** 
RAPIQRIYGVRYTETWSFLPSLTCTGDAAPAIQHICLKHTTCFQDVVVDVDCAENTKEDQLAEISYRFQG 
*"' 0 
140 150 160 170 180 190 200 
HSV2 LETDSGLYTLSVVGLSDEARQVASVVLVVEPAPVPTPTPD .. DYDEED .. DAGVTNARRSAFPPQPPPRR 
*********** * *********** ******* * **** * * * * 
HSV1 RETDSGLYTLSVGDIKDPARQVASVVLVVQPAPVPTPPPTPADYDEDD.NDEGEDESLAGTPASGTPRLP 
* *** * * * * * * * * * * * * SA8 RPSDSGMYVLT .. VSRAPNSTAARRVVFLTVGP.RVAAAVPGGPPPLA.EGAGAEAGAAATRAPAAHPYP 
* * * * PRV CVPEAPERGIG.DYLPPEVPRLQREPPIVTPERWSPHLTVRRATPNDT.GLYTLHDASGPRAVFFVAVGD 
* * * * * * EHV1 YFVNGTVFPIL.AETRSVL.QIHRATPSIA.GVYTLHVSIDGMMKHSV.VLLTVKKPPKQPQPQPRLRVK 
* * * ** VZV KKEADQPWIVV .. NTSTLFDELELDPPEIEPGVLKVLRTEKQYLGVYIWNMRGSDGTSTYATFLVTWKGD 
210 220 230 240 250 260 
HSV2 PPVAPPTHPRVIPEVSHVRGVTVHMETLEAILFAPGETFGTNVSIH.AIAHDDGPYAMDVVWMRFD.VPS 
** *** *********** *** ***** ***** ****** ****** * ***** *** ** 
HSV1 PPPAPPRSWPSAPEVSHVRGVTVRMETPEAILFSPGETFSTNVSIH.AIAHDDQTYSMDVVWLRFD.VPT 
* ** **** * ******* * * *** **** * * *** *** ** 
SA8 HPHPIAEV ....•.. AHVHGVTVSLRTQTAILFSPGDTVHTAVSIV.PFAHDDDPYVMEVVWVRFD.VPE 
* * ******* * * * 
PRV RPPAPLAP ..... VGPARHEPRFHALGFHSQLFSPGDTFDLMPRVVSDMGDSRENFTATLDWY.YARAPP 
** * * * * ** * * * * * * ** 
EHV1 TPPPVTVP ..•.. QVPVKTHTDFVVHGYHSRVYRDGESFELSVNLESHIVEP .• SFSAEIQWYYMNTSSS 
* * * *** * * * * * * * * * 





290 300 310 320 330 
*** ***** 
HSVl SCAEMRIYESCLYHPQLPECLSPADAPCA .• ASTWTSRLAVRSYAGCSRTNP ••. PPRCSAEAHMEPVPG 
* ****** ***** **** ******** ** ** ***** * *** * **** * ** ** 
SA8 ECGEMRIYEPCLYHPRLPECRSPADAPCA •. ASVWTERLAVRRYGPCSRHVP ... PPRCPTDAAMEARPG 
* **** **** *** * * * * * * ** ** ** * PRV RCLLYYVYEPCIYHPRAPECLRPVDPACSFTSPARAALVARRAYASCSPLLGDRWLTACPFDAFGEE •.• 
* * * * ** ** * ** * ****** ** * * ** * * * * 
EHVl SCDLFRVFETCIFHPTAMACLHPEQHTCSFTSPIRATKILHRVYGNCSDH.GNSWPSRCHSTLLGNRLYF 
* *********** * * 
EHV4 GSTWPSRCHSTLLGDRPHF 
* * ** ** * ** * **** * ** ** * VZV TCQPMRLYSTCLYHPNAPQCLSHMNSGCTFTSPHLAQRVASTVYQNCEHADN .• YTAYCLGISHMEPSFG 
340 350 360 370 380 390 400 
HSVl LAWQAASVNLEFRDASPQHSGLYLCVVYVNDHIHAWGHITISTAAQYRNAVVEQPLPQRGADL.AEPTHP 
* * *** **** *** ****** * ***** **** ******* ** * * 
SA8 LGWYGPTVNLQLRDASEASGGLYVCVVYVNGHVHAWGHVVVSTAARYRNAVVERSLPRYRPP .... PAAP 
* **** * **** * * *** * * * * * PRV .•.•.••... VHTNATADESGLYVLVMTHNGHVATWDYTLVATAAEYVTVIKELTAPARAPGTPWGPGGG 
* **** * *** * *** ** * * * * 
EHVl IQPAQNRVDLLFKDTPASATGLYVFVLLYNGHPEAWTYTLLSTANHFMNVLTDVTRPRLGEHFYTDLGHK 
**** ********* * ************************************ ************ ** 
EHV4 IQPAPNRVDLLFKDIPESATGLYVFVLLYNGHPEAWTYTLLSTANHFMNVLTDRTRPRLGEHFYTDHGHQ 
* * *** * ****** *** ** ** ** ** * * * 
VZV LILHDGGTTLKFVDTPESLSGLYVFVVYFNGHVEAVAYTVVSTVDHFVNAIEERGFPPTAGQ •• PPATTK 
,c::. 
N 
410 420 430 440 450 
HSV1 .•.......... HVGAPPHAP.PTHGAL .. RLGAVMGAALLLS •... ALGLSVWACMTCWRRRAWRAVKS 
* * * * ** * **** * * ******* ** * ******* 
SA8 ..••........ TPSARPQGPRPALRSP .• RLVGVFGAALGLA ...• AAGLSVWACVTCRRARAWRAVKK 
* *** * * ** * ** ** * * ** PRV DDAIYVDGVTTPAPPARPWNPYGRTTPG .. RLFVLALGSFVMTC ..• VVGGAVWLCVLCSRRRAASRPFR 
** * * * ** * ** * * * EHV1 .•...... IITPHPSVA ..•. TTEELGAWTRHYLAFLLVIICTCAALLVALVVWGCILYIRSNRKPYEVL 
***** * ** ************** ********* ********************* 
EHV4 ••••.... LFTPHPSEA .••. TTQELGAWTRHYLAFLLIIICTCAALLIALVVWGCILYIRSNRKPYEVL 
** *** ** * * VZV ..••.. PKEITP ... VNPGTSPLLRYAAWTGG.LAAVVLL.CLVIFLICTA 
460 470 480 490 500 510 520 
HSV1 RASGKGPTYIRVAYSELYADWSSDS .. EGERDQVPWLAPPERPDSPSTNGSGFEILSPTAPSVYPRSDGH 
* * **** * ***** *** * * * * **** *** * * * SA8 RDPGT.QTYIRLADDELYADLSSDGGWEDSEDDDSDDDRLPGTDRPPKRGSGFQILSGTKAD •. PWSPEA 
* * * * * * PRV VPTRAGTRMLSPVYTSLPTHEDYYDGDDDDEEAGDARRRPSSPGGDSGYEGPYVSLDAEDEFS.SDEDDG 
* * * * EHV1 NPFETVYTSVPSNDPSDEVLVFERLASDSDDSFDSDSDEELEYPPPPKPAPQ.LPPYQFVDGGDAPSGRS 
*************** ******************* ****** * ** ** * * ** ** *** 
EHV4 NPFETVYTSVPSNDPTDEVLVFERLASDSDDSFDSSSDEELELPQPP.PAAQ.LQPYSSLESADASRGRS 
* ** ** * * * 
VZV KRMRVKAYRVDKSPYNQSMYYAGLPV ... DDFEDSESTDTEEEFGNAIGGSHGGSSYTVYIDKTR 
~ 
w 
530 540 550 
HSVl QSRRQLTTFGSGRPDR.RYSQASDSSVFW 
* * ** * * * 
SAS RRGRDLVTFRVDDAARYRDASPPDPPHRR 
* * ** * PRV LYVRPEEAPRSGFDVWFRDPEKPEVTNGPNYGVTASRLLNARPA 
* * ** * ** * EHVl GFKVWFRDTPEASPVPLHKPTL .... QGPDYSRVASKLKSILK 
************** *** ** ***** ***** **** 
EHV4 GFKVWFRDTPEASPEPLHRPTP .•. PVGPDYSKVASKLRSILK 
these viruses was more completely assessed by using the 
UWGCG program GAP to generate pairwise alignment scores 
for SA8, PRV, EHVl and VZV gE sequences with the HSVl 
sequence. Table 2 summarize the results. The predicted 
amino acid sequences of gE polypeptides show 49.1% identi-
ty between the SA8 and HSVl, 27.8% between PRV and HSVl, 
23.4% between EHVl and HSVl and 24.2% between VZV and 
HSVl. In addition, the results of pairwise similarity 
scores were used to hierarchically cluster gE sequences 
with other sequences, with the most closely related se-
quences being clustered together. The SA8 gE sequence was 
more closely related to the HSVl and HSV2 gEs than to the 
gEs of the other 4 viruses (Figure 8). 
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TABLE II 









PRV EHV1 vzv 
27.8 23.4 24.2 
49.1 42.5 45.0 
1) Only partial sequence is available for the HSV2 gE gene; 
these values are based on the first 280 amino acids of the 
HSVl & HSV2 gE sequences. 
2) Percent of positions in the aligned sequences where an iden-
tical amino acid occurs in both sequences. 
3) Percent of positions in the aligned sequences where similar 








Comparison of the partial DNA sequences of several 
SA8 subclones to the DNA sequence of the HSV1 Us region 
(37) identified regions of homology with the US3, US6(gD), 
US7(gi), US8(gE) and US10 genes of HSV1. Based on com-
parison of the distances between these regions of homology 
and the relative orientation of the SA8 and HSV1 sequences 
(Figure 3), it is apparent that both the order and orien-
tation of these five genes are the same in SA8 as in HSV1. 
Although this needs to be confirmed with additional stud-
ies, the results do suggest that the Us region of SA8 is 
co-linear with the HSV1 Us region. At the least we can 
say that no major insertions or deletions exist in the SA8 
Us region relative to the HSV1 Us region. 
Comparison of the DNA sequence and the predicted 
amino acid sequence of SA8 gE with the HSV1 gE show sig-
nificant homology at both the DNA and amino acid levels. 
The SA8 gE gene ORF is 1602 bp and 58.8% identical to the 
HSV1 gE gene ORF (1650bp). At the level of the amino acid 
sequence, the HSV1 and SA8 gE polypepetides are 49.1% 
identical and 64.7% similar to each other. 
Both pairwise comparison and cluster analysis of 
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HSVl, SA8, PRV, EHVl, VZV and a portion of the HSV2 and 
EHV4 gE amino acid sequences further demonstrate that the 
SA8 gE is more similar to the HSVl (and HSV2) gE than it 
is to the PRV, VZV, EHVl or EHV4 gEs. Although only 280 
amino acids of the HSV2 gE sequence were available for 
analysis, it was still apperent that the HSV2 gE is more 
closely related to HSVl gE than to the SA8 gE. This 
result parallels that obtained for the gB polypeptides of 
these same viruses (81). This may indicate that some 
evolutionary pressure is applied equally to all herpesvi-
rus glycoproteins. Adaptation of the viral surface anti-
gens to surface determinants of cells of their particular 
host species is one such possible pressure. 
Multiple alignments demonstrated that in the C-termi-
nal half of the extracellular hydrophilic region there is 
significant sequence homology among the HSVl, SA8, PRV, 
VZV, EHVl and EHV4 gEs. The amino acid sequences in this 
region are quite similar and six of the seven cys residues 
are conserved. The strongly conserved nature of this 
region implies a structural similarity in this region for 
the gEs of all these viruses. Since this region is locat-
ed in the extracellular domain, it is possible that it 
serves an important function. One obvious functional 
possibility is binding the Fe region of anti-viral IgG. 
It is of interest that the identity of gE gene DNA 
sequences (58.7%) between SA8 and HSVl is higher than 
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their amino acid identity (49.1%). This is the reverse of 
what is commonly observed for related genes. One possible 
reason that could explain this is the high G+C content of 
these two genes. The high G+C content in the gE genes of 
both SA8 (76.2%) and HSV1 (66.6%) limit the frequency for 
use of A or T in the coding sequences. The high G+C 
content also results in almost exclusive use of only G or 
c in the 3rd position of codons (Table 3). Because of the 
strong bias in HSV1 and especially SA8 for codons with G 
or c in the 3rd position, the probability of having a non-
identical base in the 3rd position is considerably re-
duced. For example, where Gly could usually be coded for 
by any one of four possible codons (GGA, GGC, GGG, or 
GGT), due to the strong GC bias in HSV1 and SA8 the only 
practical possibilities for Gly are GGC and GGG. This 
usually increases the probability of DNA homology in the 
3rd position and, thus, in the gene overall. 
Summary 
The purpose of this study was to determine if SA8 has 
a homolog of the HSV1 gE gene within the Us region and, if 
so, to clone and sequence this gene. Since the gE gene is 
located within the Us region of HSVl, the BamHI D fragment 
(about 10 Kbp) containing most Us region of SA8 was 
cloned. DNA sequencing of the terminal sequences of a 
number of subclones of this 10 Kbp BamHI D fragment of SA8 
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Table III 
COMPARISON OF CODON USAGE AND PREDICTED AMINO ACID 
COMPOSITION OF SA8 AND HSVl gEs 
% Codons with G/C in: 
No. Residues 3rd Position 1st Position 
AA SA8 HSVl Avg1 SA8 HSVl Avg SA8 HSVl 
Non-Polar: 
Ala 74 60 50 93.2 88.3 
Ile 7 11 33.3 71.4 45.4 
Leu 35 41 50 97.1 80.5 66.7 100 80.5 
Met 6 10 100 
Phe 10 9 50 90.0 55.6 
Pro 64 65 50 92.2 78.5 
Trp 13 15 
Val 56 50 50 92.9 82.0 
Polar: 
Asn 6 8 50 100 62.5 
Cys 11 13 50 100 30.8 
Gln 7 16 50 100 75.0 
Gly 47 38 50 91.5 78.9 
Ser 30 52 50 96.7 75.0 
Thr 26 32 50 96.2 87.5 
Tyr 14 15 50 92.9 80.0 
Acidic: 
Asp 32 29 50 93.8 69.0 
Glu 22 26 50 100 69.2 
Basic: 
Arg 57 38 50 87.7 71.1 66.7 94.7 78.9 
His 16 16 50 93.8 75.0 
Lys 5 6 50 80.0 50.0 
1) Values represent the expected frequency of occurrence of G/C vs 
A/T if all codon choices were utilized with equal frequency. 
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indicated that the Us region of SA8 is co-linear with the 
Us region of HSV1, since the sequenced regions of this 10 
Kbp fragment were found to have good homology with the 
US3, US6(gD), US7(gi), US8(gE), and US10 genes of HSV1 and 
distances between these homologous sequences in HSV1 and 
SA8 were also similar. Both strands of subclones spanning 
the SA8 gE gene homolog were sequenced completely. The 
entire sequence of the SA8 gE gene was assembled based on 
overlapping sequences. The SA8 gE gene ORF is 1602 base 
pairs long and has 58.8% identity with the HSV gE ORF at 
the DNA level. The predicted amino acid sequence of the 
SA8 gE gene product is 534 residues in length and showed 
49.1% identity and 64.7% similarity to the HSV1 gE. The 
predicted secondary structural properties of the SA8 gE 
polypeptide were very similar to those predicted for the 
HSVl gE polypeptide. They included a small N-terminal 
hydrophobic signal peptide (about 21-25 AAs), a conserved 
N-linked glycosylation site, an long hydrophilic region 
representing the extracellular domain, a hydrophobic 
transmembrane domain, and a highly charged and divergent 
cytoplasmic tail domain. A highly conserved region in the 
extracellular domain was apparent which extended from SA8 
gE amino acid 205-401. This region was located adjacent 
to the transmembrane domain. This conserved region of the 
SA8 gE polypeptide had 63% amino acid sequence identity 
with the corresponding region of HSVl gE polypeptide. All 
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seven Cys residues located in this region were conserved 
between HSVl and SA8. Other predicted secondary structure 
features also indicated that the structure of this region 
is very similar in both HSVl and SA8 gE polypeptides. 
Multiple sequence alignment of seven gE amino acid se-
quences and hierarchical cluster analysis of these seven 
gE sequences indicated that the SA8 gE is more similar to 
the HSVl gE than the PRV, VZV, or EHVl gE homologs. 
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